NVZMF
Price:
$58.29
Market Cap:
$24.59B
Novozymes A/S, a Danish enterprise established in 1925 and headquartered in Bagsvaerd, is a leading provider of biological solutions, specializing in the production and global distribution of industrial enzymes, microorganisms, and probiotics. Its extensive reach spans across Europe, the Middle East, Africa, North America, Asia Pacific, and Latin America. The company's diverse portfolio caters to a wide array of sectors, including the food and beverage industry with innovations for baking, beverages, dairy, starch processing, and protein applications. In household care, its products enhance laundry, dishwashing, and professional cleaning. For agriculture, Novozymes supports crop production w...[Read more]
Industry
Chemicals - Specialty
IPO Date
2010-10-15
Stock Exchange
OTC
Ticker
NVZMF
According to Novozymes A/S’s latest financial reports and current stock price. The company's current Enterprise Value is 27.47B. This represents a change of -85.42% compared to the average of 188.44B of the last 4 quarters.
The mean historical Enterprise Value of Novozymes A/S over the last ten years is 120.50B. The current 27.47B Enterprise Value has changed 2.18% with respect to the historical average. Over the past ten years (40 quarters), NVZMF's Enterprise Value was at its highest in in the September 2024 quarter at 234.81B. The Enterprise Value was at its lowest in in the December 2016 quarter at 74.04B.
Average
120.50B
Median
104.80B
Minimum
74.15B
Maximum
191.23B
Discovering the peaks and valleys of Novozymes A/S Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 73.70%
Maximum Annual Enterprise Value = 191.23B
Minimum Annual Increase = -30.61%
Minimum Annual Enterprise Value = 74.15B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 191.23B | 1.67% |
| 2024 | 188.09B | 73.70% |
| 2023 | 108.28B | 4.86% |
| 2022 | 103.26B | -30.61% |
| 2021 | 148.82B | 46.33% |
| 2020 | 101.70B | 4.91% |
| 2019 | 96.94B | 12.45% |
| 2018 | 86.21B | -18.93% |
| 2017 | 106.34B | 43.40% |
| 2016 | 74.15B | -27.01% |
The current Enterprise Value of Novozymes A/S (NVZMF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
162.53B
5-year avg
147.94B
10-year avg
120.50B
Novozymes A/S’s Enterprise Value is greater than Symrise AG (13.57B), less than Givaudan S.A. (33.69B), less than Sika AG (30.97B), less than Sika AG (30.97B), greater than Akzo Nobel N.V. (13.37B), less than L'Air Liquide S.A. (114.13B), greater than Asia Carbon Industries, Inc. (-5294824.00), greater than Akzo Nobel N.V. (13.37B), less than Avoca LLC (0), less than The Sherwin-Williams Company (92.69B), less than Air Products and Chemicals, Inc. (79.80B), less than Linde plc (259.28B), less than Ecolab Inc. (84.49B), greater than RPM International Inc. (16.44B), less than PPG Industries, Inc. (32.51B), less than LyondellBasell Industries N.V. (31.00B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 13.57B | $13.65B | |
| 33.69B | $36.92B | |
| 30.97B | $31.40B | |
| 30.97B | $32.86B | |
| 13.37B | $34.94B | |
| 114.13B | $121.21B | |
| -5294824.00 | $5.61K | |
| 13.37B | $11.47B | |
| 0 | $9.71M | |
| 92.69B | $79.12B | |
| 79.80B | $62.40B | |
| 259.28B | $236.92B | |
| 84.49B | $75.74B | |
| 16.44B | $13.83B | |
| 32.51B | $26.35B | |
| 31.00B | $19.39B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novozymes A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novozymes A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Novozymes A/S's Enterprise Value?
What is the highest Enterprise Value for Novozymes A/S (NVZMF)?
What is the 3-year average Enterprise Value for Novozymes A/S (NVZMF)?
What is the 5-year average Enterprise Value for Novozymes A/S (NVZMF)?
How does the current Enterprise Value for Novozymes A/S (NVZMF) compare to its historical average?